Clinical Testing of Limb-Girdle Muscular Dystrophy (LGMD2A and LGMD2B)
We test for point mutations in Calpain-3, CAPN3 (autosomal recessive limb-girdle muscular dystrophy-2A, see GeneReview) and Dysferlin, DYSF (autosomal recessive limb-girdle muscular dystrophy-2B, see GeneReview). You will be responsible for the costs of having the blood drawn, and for shipping it by overnight courier to the University of Utah Genome Center. In order for your sample to be processed, you need to send along the information/billing and DNA testing consent form.
Methodology
Fluorescence-based, bidirectional Sanger dideoxy sequencing of PCR amplicons spanning all coding regions and intron/exon boundaries for:
- CAPN3 gene
- DYSF gene
Capillary electrophoresis is performed using an ABI 3730xl DNA Analyzer.
Costs
- $1,500 Direct sequencing analysis of the CAPN3 and DYSF genes
- $1,250 Direct sequencing analysis of the DYSF gene
- $1,150 Direct sequencing analysis of the CAPN3 gene
- $250 Sequencing of a single exon (For family members of patients with previously detected mutations)
Results
Your physician will receive results by e-mail and mail in approximately six (6) to eight (8) weeks.
Ordering Procedure
- Print out the information/billing and DNA testing consent form for Duchenne/Becker muscular dystrophy. You and your physician must fill out the form and send it along with the blood sample.
- Print out the UofU blood shipping instructions and take them with you to your doctor or a blood drawing laboratory.
- Print out the CPT Codes for insurance claims.
If you have questions about this testing please contact:
Diane Dunn, B.S.
Laboratory Supervisor
Phone: (801) 585-3436